Custodian of the world's first fully matched allogeneic iPSC cell bank with 65+ super donors covering over 90% of the US population. Develops off-the-shelf allogeneic iPSC-derived stem cell therapies for cardiac, neurological, and osteoarthritis indications and participates in a government program to regenerate human body components.